Godfrey Financial Associates’s Biogen BIIB Stock Holding History

Godfrey Financial Associates’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.02K	Hold	14	–	–	﹤0.01%	616
2026 Q1	$2.57K	Hold	14	–	–	﹤0.01%	615
2025 Q4	$2.46K	Buy	+14	New	+$2.29K	﹤0.01%	604

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Godfrey Financial Associates's BIIB Position: Q2 2026 in Review

Godfrey Financial Associates held its Biogen (BIIB) position steady in Q2 2026 at 14 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Godfrey Financial Associates first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Godfrey Financial Associates held 14 shares of Biogen worth $3.02K as of Q2 2026.
Godfrey Financial Associates left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Godfrey Financial Associates's portfolio in Q2 2026, its #616 holding.
Godfrey Financial Associates first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.